NSPR | InspireMD, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	2.4408 - 2.5700
52 Week Range	1.8100 - 3.48
Beta	1.19
Implied Volatility	53.92%
IV Rank	8.03%
Day's Volume	31,100
Average Volume	17,103
Shares Outstanding	25,706,700
Market Cap	63,495,549
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2011-04-12

Valuation
Profitability
Growth
Health
P/E Ratio	-4.05
Forward P/E Ratio	N/A
EPS	-0.61
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	68
Country	Israel
Website	NSPR

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions, as well as bypass surgery. It is also developing PVGuard, a MicroNet mesh sleeve and self-expandable stent for use in peripheral vascular applications. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

NSPR's peers: BBLG, TIVC, BJDX, VVOS, RPID, SGHT, SSKN, NPCE, VAPO, TLIS, NUWE, RSLS, TNON, RMED, INVO, AZYO, AIMD, SRDX, LNSR, IRIX

*Chart delayed

Analyzing fundamentals for NSPR we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is weak. For more detailed analysis please see NSPR Fundamentals page.

Watching at NSPR technicals we can see that long-term trend is bullish, while middle-term trend is bearish, as well as bearish short-term trend. More technicals details can be found on NSPR Technicals page.